Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Groundbreaking Ceremony Marks Start of Work to Build Medical Student Accommodation
Just six weeks after planning permission was granted, construction work to build medical student accommodation […]
Aristea Appoints Justin Thacker as Chief Financial Officer
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat […]
Yposkesi Joins BioPhorum - Global Cell and Gene Therapy Consortium
Yposkesi, a best-in-class Contract Development and Manufacturing Organization (CDMO) for companies developing cell and gene […]
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Pfizer Inc.and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) approved […]
Nationwide Roll-Out of NHS High Street Heart Checks to Save Thousands of Lives
Thousands of lives will be saved thanks to more blood pressure checks in high street […]
Government Launches First UK-wide Antibody Surveillance Programme
Thousands of adults a day will be given free access to antibody tests through a […]
VEON's Beeline to Bring Mobile AI Technology to Medical Diagnosis and Research
VEON Ltd. (NASDAQ: VEON), a leading global provider of connectivity and internet services, announces that its […]
Elixiron Immunotherapeutics Announces Closing of $27 Million Series A-1 Financing Round to Progress Alzheimer's Disease and Vitiligo Clinical-Stage Assets
Elixiron Immunotherapeutics, Inc., a privately held company developing therapeutics for cancer, neurological diseases and inflammatory […]
Xeljanz ® (Tofacitinib Citrate) Receives Marketing Authorization in the European Union for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has approved XELJANZ ® (tofacitinib) […]
Healthtech Startup bttn. Announces $5M Seed Add-on to Modernize Medical Supply Market
Healthtech startup bttn. announced it has closed a $5M add-on to its seed round led by FUSE. The B2B E-commerce platform […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more